6 Recruiting Epithelial Ovarian Cancer Phase 1 Clinical Trials
Active phase 1 studies for epithelial ovarian cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Epithelial Ovarian Cancer studiesPhase 1 Studies for Epithelial Ovarian Cancer
🔵 Active, Not Recruiting Phase1
Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian
📍 Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)
📍 University of Alabama Birmingham — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)
📍 Los Angeles Hematology Oncology Medical Group — Glendale, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
T-regulatory Cell Depletion With E7777 Combined With Pembrolizumab in Recurrent or Metastatic Solid Tumors
📍 UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase1
EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma
📍 Fred Hutch Cancer Center — Seattle, Washington
View Study & Checklist ➔ 🟢 Recruiting Phase1
A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔